pharma · HIV Infections · Major Depressive Disorder · PRAX
Praxis Precision Medicines
Praxis Precision Medicines is a pharma organization headquartered in Boston, USA. It trades on NYSE under ticker PRAX. Primary therapeutic focus areas include HIV Infections, Major Depressive Disorder, Pancreatic Cancer,
Boston, USA HQ
205 Employees
Public company Type
PRAX · NYSE Ticker
Company details
- Status
- Public
- HQ
- Boston, USA
- Employees
- 205
- Programs
- 7
- Drugs
- 8
- Patents
- 35
Nimotuzumab
Phase 3 · small molecule · Pancreatic Cancer, Advanced or Metastatic
Nimotuzumab for Pancreatic Cancer, Advanced or Metastatic is a Phase 3 program (small_molecule) at Praxis Precision Medicines with 1 ClinicalTrials.gov record(s).
Internal code OSAG101-PCS07
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Praxis Precision Medicines
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Pancreatic Cancer, Advanced or Metastatic
- Status
- completed
- Trials
- 1